Maternal zinc supplementation improves hepatitis B antibody responses in infants but decreases plasma zinc level

2015 ◽  
Vol 55 (5) ◽  
pp. 1823-1829 ◽  
Author(s):  
Shaikh Meshbahuddin Ahmad ◽  
Mohammad Bakhtiar Hossain ◽  
Md. Monirujjaman ◽  
Sharmin Islam ◽  
Md. Nazmul Huda ◽  
...  
2019 ◽  
Vol 14 (2) ◽  
pp. 115
Author(s):  
Putri Hersya Maulia ◽  
Farapti Farapti

Zinc has a potential role in defense system by taking control in immunity cells activity. Zinc is a micro-nutrient that attains in such prominence as a co-factor for hundred enzymes and inducing nutritional metabolism. In condition of HIV infection, low plasma zinc level can inhibit T cell establishment, then decreasing humoral and cellular immunity. Furthermore, zinc plasma defi ciency will impact the disease progression thus increasing mortality rate. Based on several studies, giving zinc supplementation to HIV/AIDS patient still shows controversial results. The aim of this systematic review was to analyze zinc status in HIV/AIDS patients and examine the effect of zinc supplementation related to immunity status. The method of the study was conducted comprehensive searches on adults HIV infected aged >18 years who underwent outpatient care or hospitalized that received single zinc supplementation or in multivitamin and minerals form. The result from nine studies demonstrated that most of HIV/AIDS patients have a low plasma zinc level and after receiving zinc supplementation with a dose at least 12 mg for more than 1 month consecutively, the lymphocytes CD4+ and IFN-γ status in HIV/AIDS patients was increasing. Furthermore, the intervention of zinc supplementation also showed some positive improvement in other infections occurrence such as diarrhea, pneumonia, and tuberculosis. Zinc supplementation on HIV/AIDS patient has many benefi ts in increasing zinc status and improving the immune system.


1970 ◽  
Vol 16 (1) ◽  
pp. 12-14 ◽  
Author(s):  
Nasima Akhtar ◽  
Raghib Ahsan ◽  
Md Abdul Wakil ◽  
CGM Mostafa ◽  
Sakhi Chowdhury ◽  
...  

End stage renal disease (ESRD) patients receiving haemodialysis (HD) are frequently associatedwith anaemia. Zinc, being an important nutrient for haemoglobin synthesis, was studied for it'seffect, if any, on renal disease associated anaemia among patients in the HD unit of BSMMU(formerly IPGMR), Dhaka. Surprisingly, a tow plasma zinc level and a high corpuscular (RBC)zinc level was observed. All of our subjects were found anaemic. A significant correlation wasobserved between plasma zinc level on one hand and haemoglobin level as well as RBC countson the other hand. There are several suggestions for this low plasma and high corpuscular zinclevel. However, this altered zinc level in plasma and red blood corpuscles might interfere withhaemoglobin synthesis and might be one of the factors for renal disease associated anaemia.doi: 10.3329/taj.v16i1.3895TAJ June 2003; Vol.16(1): 12-14


2016 ◽  
Vol 8 (1) ◽  
pp. 9
Author(s):  
Parveen Fatima ◽  
Nurjahan Begum ◽  
Shakeela Lshrat ◽  
Jesmin Banu ◽  
Shaheen Ara Anwary ◽  
...  

<p><strong>Background:</strong> Inferile males have been shown to have lower levels of seminal plasma zinc which have been associated with reduced levels of zinc in their blood. Supplementation improve semen parameters by improving zinc level in blood. </p><p><strong>Objective:</strong> To fnd out whether zinc supplementation is effective in improving semen parameters in oligo­asthenozoospermic patients.</p><p><strong>Method:</strong> The study was carried out in the Infertility unit of the Dept of Obs &amp; Gynae, BSMMU during the period of March 2011 to February 2012. Seventy five oligo-asthenozoospermic patients having no history of medical treatment were recruited for the study. The patients were divided into two groups by odd and even numbers. Odd numbers received tablet zinc 20 mg twice daily (Group A) and even numbers received placebo (Group B).Serum zinc level and seminal zinc level estimation were done by Graphite Furnace Atomic Absorption Spectropho­tometry and semen analysis was done according to WHO guidelines (1999). Data analysis was done using software SPSS (version 16) by applying ANOVA (PostHock) and Paired Student's 't' test.</p><p><strong>Results:</strong> Serum zinc level was low in oligo­zoospermic patients which showed significant improvement with zinc supplementation (A+ 197.83 mmol/1, P&lt;0.01). Mean (±SD) seminal plasma zinc level showed significant improvement in group A following zinc supplementation (+942.39 mmol/L, P&lt;0.001). The mean increase in sperm count, sperm motility, sperm rapid linear motility, sperm morphology in group A following zinc supplementation for 12 weeks was 14.83 million/ml (P&lt;0.01), 16.30% (P&lt;0.01), 11.96% (P&lt;0.01), 4.26% (P&lt;0.001) respectively, which was statistically significant.</p><p><strong>Conclusion:</strong> The study shows zinc deficiency affects sperm count, sperm motility, rapid linear motility and sperm morphology and with zinc supplementa­tion there can be significant improvement in semen parameters.</p>


1995 ◽  
Vol 95 (11) ◽  
pp. 1274-1279 ◽  
Author(s):  
BARBARA M RETZLAFF ◽  
CAROLYN E WALDEN ◽  
WILLIAM B McNENEY ◽  
ALICE A DOWDY ◽  
ROBERT H KNOPP

PEDIATRICS ◽  
1982 ◽  
Vol 70 (4) ◽  
pp. 661-661
Author(s):  
Andrew W. Zimmerman

Tasic and colleagues are correct in pointing out the potential hazards of zinc toxicity in treating infants with acrodermatitis due to low zinc in their mothers' milk. Infants, especially premature infants, who have symptoms of acrodermatitis enteropathica while being breast-fed should be assumed to have normal capacity for uptake of zinc in the gut. If breast-feeding is continued during administration of zinc, the plasma zinc level can be expected to rise rapidly. This is due in part to the positive effect of human breast milk on zinc absorption as well as normal absorptive capacity.


Blood ◽  
1994 ◽  
Vol 83 (3) ◽  
pp. 749-757 ◽  
Author(s):  
E Mocchegiani ◽  
P Paolucci ◽  
D Granchi ◽  
L Cavallazzi ◽  
L Santarelli ◽  
...  

Abstract It has been reported that in many neoplastic diseases, including leukemia, alterations in plasma zinc levels may frequently occur, although the causes for such alterations have yet to be clearly defined. Since zinc is required to induce biological activity to thymulin (Zn-FTS), a biochemical defined thymic hormone, and marginal zinc deficiencies may prevent its peripheral biological activation, we investigated the plasma level of zinc and of both active thymulin (Zn- FTS) and total zinc saturable thymulin (Zn-FTS + FTS) in 91 young patients affected by acute lymphoblastic leukemia (ALL) at various stages of the disease. It was discovered that the plasma zinc level was reduced at the onset and relapse, whereas in complete remission and in off-therapy it was in the normal range. Total zinc-saturable thymulin concentration did not change during the disease, whereas the active fraction was reduced at the onset and in relapse when compared with values observed in the other stages of the disease or in healthy controls. These data suggest that zinc plasma deficiency is present in ALL patients at the onset and during relapse, and that such a deficiency causes a decrease in the activity of thymulin despite a nearly normal production by the thymus. An impairment of peripheral immune efficiency in ALL patients is commonly found. The existence of positive correlations between zinc or active thymulin and peripheral immunological parameters (phytohemagglutinin [PHA] and concanavalin A [ConA]) at various stages of the disease suggests a link between derangement of peripheral immune function, thymic hormone activity, and zinc failure. These findings, considered together, suggest the possibility of a carefully controlled clinic trial with zinc in ALL patients at the onset and in relapse even in the light of in vitro ineffectiveness of physiological zinc or thymulin concentrations on the duplicative index of human lymphoblastoid cells.


2012 ◽  
Vol 10 (2) ◽  
pp. 32-34
Author(s):  
Nabin Bhakta Shakya ◽  
Sudarsan Lal Rajbhandari ◽  
Sagar Mani Jha

Acrodermatitis enteropathica is rare congenital autosomal recessive disorder. Premature are particularly risk and disease is caused by zinc deficiency due to a specific absorptive defect. This disease manifests in child as peevish, withdrawn and photophobia and develop vesicobullous dermatitis on hands, feet and perioroficial areas and alopecia. Diarrhea is often present. This also presents as shunted growth and decrease resistance to infection. Poor wound healing. A low plasma zinc level and Serum alkaline phosphatase are useful indicator of zinc status. DOI: http://dx.doi.org/10.3126/mjsbh.v10i2.6461 Medical Journal of Shree Birendra Hospital July-Dec 2011 10(2) 32-34


Sign in / Sign up

Export Citation Format

Share Document